{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 2-Fluoro-4-[5,5,5-trifluoro-3-(3-fluoro-4-hydroxyphenyl)pentan-2-yl]phenol
| image = Pentafluranol.svg
| width =

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 65634-39-1
| CAS_supplemental = 
| ATC_prefix = None
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 3047826
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 16737041
| UNII = 95RFZ48151
| KEGG = 
| ChEBI = 
| ChEMBL = 2105409

<!--Chemical data-->
| C=17 | H=15 | F=5 | O=2
| molecular_weight = 346.291816 g/mol
| smiles = CC(C1=CC(=C(C=C1)O)F)C(CC(F)(F)F)C2=CC(=C(C=C2)O)F
| StdInChI_Ref = 
| StdInChI = 1S/C17H15F5O2/c1-9(10-2-4-15(23)13(18)6-10)12(8-17(20,21)22)11-3-5-16(24)14(19)7-11/h2-7,9,12,23-24H,8H2,1H3
| StdInChIKey_Ref = 
| StdInChIKey = PRRSFMGODMUPJN-UHFFFAOYSA-N
| synonyms = 
}}

'''Pentafluranol''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]) (developmental code name '''BX-430''') is a [[synthetic compound|synthetic]], [[nonsteroidal]] [[estrogen]] of the [[stilbestrol]] group related to [[diethylstilbestrol]] that was developed for the treatment of [[benign prostatic hyperplasia]] never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PP1|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|page=1161}}</ref><ref name="Polonii1984">{{cite book|author=Polska Akademia Nauk. Komitet Badania Polonii|title=II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów|url=https://books.google.com/books?id=_-VjAAAAIAAJ|year=1984|publisher=Zakład Narodowy im. Ossolińskich|isbn=978-83-04-01670-5|page=451}}</ref> It was described in the medical literature in 1974.<ref name="Elks2014" />

==See also==
* [[Acefluranol]]
* [[Bifluranol]]
* [[Terfluranol]]

==References==
{{Reflist|2}}

{{Estrogen receptor modulators}}

[[Category:Organofluorides]]
[[Category:Phenols]]
[[Category:Synthetic estrogens]]
[[Category:Fluoroarenes]]
[[Category:Trifluoromethyl compounds]]


{{genito-urinary-drug-stub}}